ATHENEX PHARMACEUTICAL DIVISION Furosemide Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Furosemide from India and how much does ATHENEX PHARMACEUTICAL DIVISION import?

India exports Furosemide to 778 buyers globally worth $30.7M. ATHENEX PHARMACEUTICAL DIVISION imports $1.1M (1.6% market share) with 23 shipments from UNITED STATES.

Q: What is the average order value for ATHENEX PHARMACEUTICAL DIVISION's Furosemide imports?

ATHENEX PHARMACEUTICAL DIVISION's average Furosemide order value is $47.3K per consignment, based on 23 shipments totaling $1.1M.

Q: Who supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?

ATHENEX PHARMACEUTICAL DIVISION sources Furosemide from 1 verified supplier: MAIVA PHARMA PRIVATE LIMITED ($1.1M, 100.0%). Based on 23 customs records.

Q: How does ATHENEX PHARMACEUTICAL DIVISION compare to other Furosemide importers?

ATHENEX PHARMACEUTICAL DIVISION ranks #10 among 778 Furosemide importers from India with 1.6% market share and 23 shipments.

Q: Who are the top Furosemide importers from India?

Top Furosemide importers: RISING PHARMA HOLDINGS, INC. ($6.3M), RISING PHARMA HOLDINGS INC ($4.2M), RISING PHARMA HOLDINGS INC,., ($3.6M), BAXTER HEALTHCARE CORPORATION ($3.1M), SALUTAS PHARMA GMBH ($2.1M).

Suresh Sormare

Furosemide

India Pharmaceutical Trade Intelligence

$70.5M333 Suppliers150 CountriesHS 30049099

ExportsIndia → UNITED STATES60.2%India → CANADA7.3%

ImportsCANADA → India$79.8K GERMANY → India$43.9K

#1 Supplier: BAXTER PHARMACEUTICALS #1 Buyer: BAXTER HEALTHCARE

ATHENEX PHARMACEUTICAL DIVISION — Furosemide Importer #10 | $1.1M Trade Value | TransData Nexus | TransData Nexus

ATHENEX PHARMACEUTICAL DIVISION — Furosemide Importer Profile

Pharmaceutical Importer · #10 buyer for Furosemide · $1.1M import value · 23 shipments · UNITED STATES · DGFT Verified

ATHENEX PHARMACEUTICAL DIVISION is the #10 importer of Furosemide from India with $1.1M in import value and 23 verified shipments. ATHENEX PHARMACEUTICAL DIVISION holds a 1.6% market share in Furosemide imports based in UNITED STATES. The company sources from 1 verified supplier across 8 formulations shipped to 1 country.

ATHENEX PHARMACEUTICAL DIVISION — Furosemide Import Profile: Suppliers, Formulations & Sources

ATHENEX PHARMACEUTICAL DIVISION — Furosemide import analysis from Indian Customs (DGFT) data.

Who Actually Supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?

Verified from 23 customs shipment records

Supplier	Value	Shipments	% Share
MAIVA PHARMA PRIVATE LIMITED	$1.1M	23	100.0%

ATHENEX PHARMACEUTICAL DIVISION sources Furosemide from 1 verified Indian supplier based on 23 customs records. The primary supplier is MAIVA PHARMA PRIVATE LIMITED accounting for 100.0% of imports.

How Does ATHENEX PHARMACEUTICAL DIVISION Compare to Nearest Furosemide Importers?

Buyers ranked immediately above and below #10 by import value

#	Buyer	Country

Where Does ATHENEX PHARMACEUTICAL DIVISION Import Furosemide To?

Destination countries from 23 verified shipments

Country	Value	Shipments	Share
UNITED STATES	$1.1M	23	100.0%

ATHENEX PHARMACEUTICAL DIVISION imports Furosemide to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.1M.

What Furosemide Formulations Does ATHENEX PHARMACEUTICAL DIVISION Import?

Formulation	Value	Shipments
FUROSEMIDE INJECTION USP 40MG PER 4 ML (	$393.6K	8
FUROSEMIDE INJECTION USP 100MG PER 10ML	$349.6K	7
FUROSEMIDE INJECTION USP 40MG PER 4ML (F	$100.0K	2
FUROSEMIDE INJECTION USP 40MG PER 4ML F	$72.1K	2
FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A025 EXP DATE 11 2024	$50.0K	1
FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A026 EXP DATE 11 2024	$50.0K	1
FUROSEMIDE INJECTION USP 100MG PER 10ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E009A008 EXP DATE 05 2024	$49.6K	1
FUROSEMIDE INJECTION USP 40MG PER 4ML FUROSEMIDE INJECTION USP 10MG PER ML BATCH NO E008A024 EXP DATE 11 2024	$22.1K	1

ATHENEX PHARMACEUTICAL DIVISION imports 8 distinct Furosemide formulations from India. The top formulation is FUROSEMIDE INJECTION USP 40MG PER 4 ML ( with 8 shipments worth $393.6K.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: ATHENEX PHARMACEUTICAL DIVISION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as ATHENEX PHARMACEUTICAL DIVISION's capped import value divided by total capped export value for Furosemide across all Indian exporters.
5.Verified Records: This page is backed by 23 individual customs records matching ATHENEX PHARMACEUTICAL DIVISION importing Furosemide, covering 8 formulations from 1 verified supplier.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 150+ countries, 778+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Furosemide

Furosemide

ATHENEX PHARMACEUTICAL DIVISION — Furosemide Importer Profile

ATHENEX PHARMACEUTICAL DIVISION — Furosemide Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?

How Does ATHENEX PHARMACEUTICAL DIVISION Compare to Nearest Furosemide Importers?

Where Does ATHENEX PHARMACEUTICAL DIVISION Import Furosemide To?

What Furosemide Formulations Does ATHENEX PHARMACEUTICAL DIVISION Import?

Regulatory Requirements: Importing Furosemide into United States

Regulatory Authority

Approval Process for Generic Furosemide

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Furosemide from India and How Much Does ATHENEX PHARMACEUTICAL DIVISION Import?

What Is the Average Order Value for ATHENEX PHARMACEUTICAL DIVISION's Furosemide Imports?

Who Supplies Furosemide to ATHENEX PHARMACEUTICAL DIVISION?

How Does ATHENEX PHARMACEUTICAL DIVISION Compare to Other Furosemide Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Furosemide Import Data for ATHENEX PHARMACEUTICAL DIVISION

ATHENEX PHARMACEUTICAL DIVISION × Furosemide

Related Analysis

Need Detailed Import Data?

Data Source

8	MARCAN PHARMACEUTICALS INC.,	CANADA	$1.2M	24	$50.0K
12	NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$1.2M	24	$50.0K
10	ATHENEX PHARMACEUTICAL DIVISION ★	UNITED STATES	$1.1M	23	$50.0K
16	EVERSANA	UNITED STATES	$1.0M	20	$50.0K
18	MINT PHARMACEUTICALS INC	CANADA	$750.0K	15	$50.0K